Fructus Mume (Wu Mei) Attenuates Acetic Acid-Induced Ulcerative Colitis by Regulating Inflammatory Cytokine, Reactive Oxygen Species, and Neuropeptide Levels in Model Rats.

Abstract

Ulcerative colitis (UC) is a chronic idiopathic inflammatory disorder of the large intestine. Fructus mume (FM), a natural food with nutritive and pharmaceutical value, has demonstrated therapeutic efficacy against UC. In this study, we investigated the protective effects and mechanisms of FM against UC. We induced UC in rats with 4% (v/v) acetic acid (AA), orally administered 0.7 or 0.325 g/kg FM and 0.3 g/kg sulfasalazine (SASP) for 7 days, and explored the responses the drugs elicited in the rats. We assessed the general conditions of the rats by the disease active index. We evaluated colon tissue damage macroscopically and by Hematoxylin & Eosin, Alcian Blue-periodic acid-Schiff, and Masson's staining, and explored the potential mechanisms of FM on inflammation, oxidative stress, and neuropeptides by measuring TNF-α, IL-6, IL-8, IL-10, MMP9, CXCR-1, SOD, GSH-px, MDA, ROS, SIRT3, SP, VIP, ghrelin, and 5-HT. FM treatment significantly attenuated colon damage and submucosal fibrosis compared with the model. It lowered serum proinflammatory TNF-α, IL-8, and colonic MMP9 and CXCR-1, and raised serum anti-inflammatory IL-10 levels. FM upregulated the antioxidant enzymes SOD, GSH-px, and SITR3 protein but inhibited ROS and MDA production. It downregulated colonic SP, VIP, ghrelin, and 5-HT. The beneficial effects of FM might be dose dependent. Around 0.7 g/kg FM and SASP displayed similar efficacy for treating AA-induced colitis in rats. Our results provide empirical evidence that FM protects against AA-induced UC in rats via anti-inflammatory and antioxidant mechanisms, and regulates neuropeptides; thus, FM may be a promising, safe, and efficacious alternative therapy for UC, if its efficacy can be confirmed in human trials.

• Authors: Zongying Xu, Xueli Zhang, Wenya Wang, Di Zhang, Yan Ma, Dongmei Zhang, Meng Chen
• Journal: Journal of medicinal food (J Med Food) Vol. 25 Issue 4 Pg. 389-401 (Apr 2022) ISSN: 1557-7600 [Electronic] United States
• PMID: 35438553 (Publication Type: Journal Article)

Chemical References

• Anti-Inflammatory Agents
• Antioxidants
• Cytokines
• Ghrelin
• Interleukin-8
• Neuropeptides
• Reactive Oxygen Species
• Tumor Necrosis Factor-alpha
• Interleukin-10
• Serotonin
• Superoxide Dismutase
• Matrix Metalloproteinase 9
• Acetic Acid

Topics

• Acetic Acid (adverse effects, metabolism)
• Animals
• Anti-Inflammatory Agents (pharmacology)
• Antioxidants (pharmacology)
• Colitis, Ulcerative (chemically induced, drug therapy, metabolism)
• Colon
• Cytokines (metabolism)
• Ghrelin (metabolism)
• Interleukin-10 (metabolism)
• Interleukin-8 (metabolism)
• Matrix Metalloproteinase 9 (metabolism)
• Neuropeptides (metabolism, pharmacology, therapeutic use)
• Rats
• Reactive Oxygen Species (metabolism)
• Serotonin (metabolism)
• Superoxide Dismutase (metabolism)
• Tumor Necrosis Factor-alpha (metabolism)